News & Analysis on Clinical Trial Services & Contract Research And Development
Biologists have shown for the first time how histatin, the naturally occurring antifungal agent in saliva, kills the oral pathogen Candida albicans, a yeast responsible for most HIV-related oral infections.
A study has suggested the hypoxia inducible gene RTP801 may serve an important mechanistic role in the development of experimental chordial neovascularisation (CNV), the principal cause of Age-related Macular Degeneration (AMD).
Two top drugstores in the US state of Florida are seeking an exemption from legislation requiring a strict paper-based pedigree for drugs throughout the supply chain, on the grounds that it is too expensive to comply.
A mathematical algorithm that predicts the effects a compound will have on a cell's molecular components, will prove significant to drug developers, who can design compounds that will act on desired targets, eliciting therapeutic responses free of...
The International Society of Pharmaceutical Engineering (ISPE) has published a new guide detailing standardized methods for the containment of powdered materials in the pharmaceutical manufacturing environment.
French company Valois has developed a new dose counter that should improve the safety of inhalers used to delivery drugs to asthmatics and people with chronic bronchitis.
Pharmaceutical companies and governments are not doing enough to combat the problem of drug counterfeiting, which is developing into an international health crisis, claim researchers.
Genaissance Pharmaceuticals has been granted a patent for a unique method of testing individuals for genetic predisposition to reduced metabolism of drugs. The ability to metabolise certain drugs linked to genetic variant is present in over 10 per...